Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

National trends in incidence rates of hospitalization for stroke in children with sickle cell disease.

McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT.

Pediatr Blood Cancer. 2013 May;60(5):823-7. doi: 10.1002/pbc.24392. Epub 2012 Nov 14.

2.

Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.

McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT.

Pediatr Blood Cancer. 2012 Jun;58(6):945-9. doi: 10.1002/pbc.23259. Epub 2011 Jul 25.

3.

Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.

Baker C, Grant AM, George MG, Grosse SD, Adamkiewicz TV.

Pediatr Blood Cancer. 2015 Dec;62(12):2076-81. doi: 10.1002/pbc.25655. Epub 2015 Jul 14.

4.

Declining stroke rates in Californian children with sickle cell disease.

Fullerton HJ, Adams RJ, Zhao S, Johnston SC.

Blood. 2004 Jul 15;104(2):336-9. Epub 2004 Mar 30.

5.

Trends in comorbid sickle cell disease among stroke patients.

Ovbiagele B, Adams RJ.

J Neurol Sci. 2012 Feb 15;313(1-2):86-91. doi: 10.1016/j.jns.2011.09.023. Epub 2011 Oct 10.

PMID:
21992814
6.

National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.

Okam MM, Shaykevich S, Ebert BL, Zaslavsky AM, Ayanian JZ.

Med Care. 2014 Jul;52(7):612-8. doi: 10.1097/MLR.0000000000000143.

7.

The excess burden of stroke in hospitalized adults with sickle cell disease.

Strouse JJ, Jordan LC, Lanzkron S, Casella JF.

Am J Hematol. 2009 Sep;84(9):548-52. doi: 10.1002/ajh.21476.

8.

Transient ischemic attack requiring hospitalization of children in the United States: kids' inpatient database 2003 to 2009.

Adil MM, Qureshi AI, Beslow LA, Jordan LC.

Stroke. 2014 Mar;45(3):887-8. doi: 10.1161/STROKEAHA.113.004526. Epub 2014 Feb 12.

9.

Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.

Payne AB, Link-Gelles R, Azonobi I, Hooper WC, Beall BW, Jorgensen JH, Juni B, Moore M; Active Bacterial Core Surveillance Team.

Pediatr Infect Dis J. 2013 Dec;32(12):1308-12. doi: 10.1097/INF.0b013e3182a11808.

10.

Burden of influenza-related hospitalizations among children with sickle cell disease.

Bundy DG, Strouse JJ, Casella JF, Miller MR.

Pediatrics. 2010 Feb;125(2):234-43. doi: 10.1542/peds.2009-1465. Epub 2010 Jan 25. Erratum in: Pediatrics. 2011 May;127(5):1007-9.

11.

Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.

Armstrong-Wells J, Grimes B, Sidney S, Kronish D, Shiboski SC, Adams RJ, Fullerton HJ.

Neurology. 2009 Apr 14;72(15):1316-21. doi: 10.1212/WNL.0b013e3181a110da.

PMID:
19365052
12.

Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.

Miller ST, Wright E, Abboud M, Berman B, Files B, Scher CD, Styles L, Adams RJ; STOP Investigators.

J Pediatr. 2001 Dec;139(6):785-9.

PMID:
11743502
13.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146. doi: 10.1002/14651858.CD003146.pub3. Review.

PMID:
28094851
14.

Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.

Kourtis AP, Bansil P, Johnson C, Meikle SF, Posner SF, Jamieson DJ.

Pediatr Infect Dis J. 2007 May;26(5):406-10.

PMID:
17468650
15.

An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes.

Bou-Maroun LM, Meta F, Hanba CJ, Campbell AD, Yanik GA.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26758. Epub 2017 Aug 12.

PMID:
28801954
16.

Trends in the hospitalization of ischemic stroke in the United States, 1998-2007.

Lee LK, Bateman BT, Wang S, Schumacher HC, Pile-Spellman J, Saposnik G.

Int J Stroke. 2012 Apr;7(3):195-201. doi: 10.1111/j.1747-4949.2011.00700.x. Epub 2011 Dec 8.

PMID:
22151527
17.

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.

Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430. Review.

18.

Risk of stroke in children: ethnic and gender disparities.

Fullerton HJ, Wu YW, Zhao S, Johnston SC.

Neurology. 2003 Jul 22;61(2):189-94.

PMID:
12874397
19.

High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease.

Raphael JL, Mei M, Mueller BU, Giordano T.

Pediatr Blood Cancer. 2012 Apr;58(4):584-90. doi: 10.1002/pbc.23181. Epub 2011 May 16.

PMID:
21584938
20.

Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.

Griessenauer CJ, Lebensburger JD, Chua MH, Fisher WS 3rd, Hilliard L, Bemrich-Stolz CJ, Howard TH, Johnston JM.

J Neurosurg Pediatr. 2015 Jul;16(1):64-73. doi: 10.3171/2014.12.PEDS14522. Epub 2015 Apr 3.

PMID:
25837886

Supplemental Content

Support Center